Stay updated on Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision labels updated: Revision v3.4.2 added and Revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded a glossary toggle and a new label 'Last Update Submitted that Met QC Criteria', along with capitalization changes to 'No FEAR Act Data'. The site revision was updated from v3.3.4 to v3.4.0.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed; this is a minor technical update with no user-facing impact. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedLocations section updated with numerous new sites across multiple US states and countries, and several sites removed. Revision: v3.3.3.SummaryDifference0.8%

- Check89 days agoChange DetectedRevision: v3.3.2 is now displayed on the page, replacing the previous Revision: v3.3.1. This appears to be a minor metadata update with no changes to the study content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib vs Docetaxel in KRAS G12C NSCLC Clinical Trial page.